V
VAXCYTE INC
NASDAQ: PCVX (Vaxcyte, Inc.)
Last update: 9 hours ago32.17
-0.89 (-2.69%)
| Previous Close | 33.06 |
| Open | 32.52 |
| Volume | 1,412,071 |
| Avg. Volume (3M) | 1,445,354 |
| Market Cap | 4,176,405,760 |
| Price / Book | 1.35 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Diluted EPS (TTM) | -3.99 |
| Total Debt/Equity (MRQ) | 2.72% |
| Current Ratio (MRQ) | 17.70 |
| Operating Cash Flow (TTM) | -459.78 M |
| Levered Free Cash Flow (TTM) | -419.13 M |
| Return on Assets (TTM) | -14.53% |
| Return on Equity (TTM) | -19.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Vaxcyte, Inc. | Bearish | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | -0.5 |
| Insider Activity | -1.5 |
| Price Volatility | 1.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.30 |
|
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 0.68% |
| % Held by Institutions | 117.40% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Kynam Capital Management, Lp | 30 Jun 2025 | 3,071,588 |
| Westfield Capital Management Co Lp | 30 Jun 2025 | 3,068,898 |
| 52 Weeks Range | ||
| Median | 38.00 (18.12%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Goldman Sachs | 12 Sep 2025 | 38.00 (18.12%) | Hold | 32.17 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| COWAN ELVIA | 33.02 | 31.99 | 1,761 | 59,270 |
| DHALIWAL HARPREET S. | - | 31.99 | -2,742 | -87,561 |
| GUGGENHIME ANDREW | - | 31.99 | -7,970 | -253,990 |
| PICKERING GRANT | - | 31.99 | -18,196 | -580,518 |
| WASSIL JIM | - | 31.99 | -7,045 | -224,685 |
| Aggregate Net Quantity | -34,192 | |||
| Aggregate Net Value ($) | -1,087,484 | |||
| Aggregate Avg. Buy ($) | 33.02 | |||
| Aggregate Avg. Sell ($) | 31.99 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PICKERING GRANT | Officer | 08 Sep 2025 | Disposed (-) | 7,356 | 32.41 | 238,408 |
| GUGGENHIME ANDREW | Officer | 08 Sep 2025 | Disposed (-) | 2,890 | 32.41 | 93,665 |
| WASSIL JIM | Officer | 08 Sep 2025 | Disposed (-) | 2,759 | 32.41 | 89,419 |
| DHALIWAL HARPREET S. | Officer | 08 Sep 2025 | Disposed (-) | 1,204 | 32.41 | 39,022 |
| COWAN ELVIA | Officer | 08 Sep 2025 | Disposed (-) | 482 | 32.41 | 15,622 |
| COWAN ELVIA | Officer | 07 Sep 2025 | Acquired (+) | 2,810 | 33.02 | 92,786 |
| PICKERING GRANT | Officer | 02 Sep 2025 | Disposed (-) | 10,840 | 31.56 | 342,110 |
| GUGGENHIME ANDREW | Officer | 02 Sep 2025 | Disposed (-) | 5,080 | 31.56 | 160,325 |
| WASSIL JIM | Officer | 02 Sep 2025 | Disposed (-) | 4,286 | 31.56 | 135,266 |
| DHALIWAL HARPREET S. | Officer | 02 Sep 2025 | Disposed (-) | 1,538 | 31.56 | 48,539 |
| COWAN ELVIA | Officer | 02 Sep 2025 | Disposed (-) | 567 | 31.56 | 17,895 |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |